Researchers at UHN’s Princess Margaret Cancer Centre have found that inactivation of the TET2 (Tet methylcytosine dioxygenase 2) gene in immune cells improves the response of immunotherapy — a type of treatment that helps the immune system attack cancer cells — in certain cancer...
HN Summary:
Prostate cancer is the most common cancer in Canadian men (beside non-melanoma skin cancers), accounting for 22 percent of all cancers.
Mirroring U.S. guidelines against PSA screening, uOttawa researchers find Canadian rates of incurable metastatic prostate cancer climbing and overall survival decreasing...